In a recent study, Nasoohi et al. suggested the relationship of “type 3 diabetes” to AD pathology, in which the metabolic syndrome consisting of oxidative stress and neuroinflammation leads to brain insulin resistance [32]. The gene discussed is INS; the disease is metabolic syndrome.